SeaCrest Wealth Management, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.

Quarter-by-quarter ownership
SeaCrest Wealth Management, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2022$266,000
-19.9%
1,825
-34.8%
0.03%
-13.2%
Q1 2022$332,000
-15.5%
2,800
-1.8%
0.04%
-11.6%
Q4 2021$393,000
+5.6%
2,850
+6.5%
0.04%
-4.4%
Q3 2021$372,000
+61.0%
2,675
+12.6%
0.04%
+60.7%
Q2 2021$231,000
+1.8%
2,375
-10.4%
0.03%
-12.5%
Q4 2020$227,000
+104.5%
2,650
+22.4%
0.03%
+68.4%
Q1 2019$111,000
+38.8%
2,165
+0.7%
0.02%
+18.8%
Q4 2018$80,000
-1.2%
2,1500.0%0.02%
+14.3%
Q3 2018$81,000
-12.9%
2,150
-8.5%
0.01%
-17.6%
Q2 2018$93,000
+78.8%
2,350
+17.5%
0.02%
+70.0%
Q1 2018$52,000
-17.5%
2,000
-14.9%
0.01%
-16.7%
Q4 2017$63,0002,3500.01%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders